They Run a tight ship, some extremely talented people involved...

They Run a tight ship, some extremely talented people involved with a prosperous track record for Large Company Transactions and Commercialising Technology.

They seem to be shrugging off the shroud of modesty and feeling more confident in the past two months as the announcements have increased in frequency and the content is far more engaging.

I believe the wider market are only beginning to understand that Pharmaust only have to replicate the Cancer Fighting ability of MPL in its newly formulated Pill ,,which Elanco are ready and waiting for ....

The PAA team are thorough , Management understand they have to be,, the data will undergo Global Scrutiny .

Patents are Strong and have circa 18 years to run , so a well protected market , that is of considerable value.

As always the proof is in the pudding but as long as MPL does what it says does on the can,, I can see Elanco wanting to jump on quickly before the SP runs away..

Elanco are swift , they paid out Aratana shareholders $230m USD in 30 days from when the ink was dry ...

I dont see this as a long term investment and I believe the market is only awakening to this .....